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ABSTRACT - Transanal endoscopic microsurgery (TEM) provides a minimally 
invasive alternative to radical surgery for excision of benign and malignant 
rectal tumors. TEM aims to provide an alternative to conventional abdominal 
surgery (low anterior resection or abdominoperineal amputations), which 
carries not inconsiderable morbidity and mortality. Based on review of the 
literature and in the  authors experience, this review present the method 
and indications for TEM.
RESUMO – A microcirurgia endoscópica transanal (TEM) é procedimento 
alternativo minimamente invasivo ao tratamento cirúrgico radical para excisão 
de tumores benignos e malignos do reto. Ela oferece possibilidade operatória 
aos procedimentos cirúrgicos convencionais (ressecção anterior baixa ou 
amputações abdominoperineais), as quais acarretam alta morbimortalidade. 
Baseada na revisão da literatura e na experiência própria dos autores, esta 
revisão tem por objetivo apresentar o método e as indicações para a TEM.
INTRODUCTION
Transanal endoscopic microsurgery (TEM) was introduced in 1984 as a minimal invasive technique allowing the resection of adenomas and early rectal carcinomas unfit for local or colonoscopic excision 
requiring, therefore, major abdominal or abdominoperineal procedures. This 
is obtained with an endoscopic view of the rectum with reduced morbidity 
and mortality rates, decreased long-term functional dysfunction, decreased 
need for temporary or definitive colostomies, absence of scar, quick hospital 
discharge and fast recovery22,31. The cost savings associated with TEM seems 
significant due to short usage of operating room, brief use of analgesics, short 
of stay, quick return to regular activities and low rate of complications27,34.
TEM was initially proposed for adenomas and early rectal carcinomas5 
and its role in rectal cancer is still subject of much debate. This article presents 
a comprehensive review about the technique focusing in the indications 
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and controversies of its use in the treatment of rectal 
neoplasms.
METHODS
Literature search was conducted with restriction 
to english language and only published material was 
considered. Search was performed at Medline, Cochrane 
library and Science Citation Index. Search terms were: 
transanal endoscopic microsurgery, TEM, rectal cancer, 
early rectal cancer and combined modality therapy.
Technique
TEM is a relatively new technique developed to 
allow excision of lesions located in the rectum. The 
patient undergoes a full bowel preparation and general 
anesthesia. Prophylactic antibiotics are performed 
routinely. Appropriate positioning of the patient in the 
operating table is crucial: supine, prone, or even lateral 
position may be required in order to keep the lesion 
positioned at six o’clock in the operating field. After 
a dilating digital exam a specially developed and well 
lubricated proctoscope (diameter: 40 millimeters, length: 
20 centimeters) is inserted through the anus and fixed 
to the operating table. The rectum is maintained dilated 
with carbon dioxide insufflation. The faceplate of the 
proctoscope has three airtight ports for insertion of 
instruments, including dissecting forceps, needle holder 
and suction cannula. A forth port is exclusive for the 
insertion of a 40 degree optic which is connected to a 
video camera that transmits the image to a conventional 
monitor. The procedure is technically challenging 
because of the narrow operating field. Distal rectal 
lesions are more challenging to resect due to difficulties 
in maintaining the gas seal and in the instrumentation.
Lesions can be excised with partial or full-thickness 
of rectal wall. The injection of saline solution in the 
submucosa in a mucosectomy fashion may be used 
to facilitate the removal of benign lesions. Wound 
closure can be achieved, when desired, with clips or 
suture stitches. The surgical specimen is pinned out and 
oriented for pathological analysis of the margins.
Indications 
The main indication for TEM is sessile rectal 
adenomas that are out of reach for transanal excision 
or that are unfit for colonoscopic removal11. TEM can 
access lesions that are up to 16 centimeters from the 
anal verge. The rectal lesion is usually resected in one 
piece, not necessarily having full thickness of the rectum 
wall, unless a malignant lesion is suspected. Diagnostic 
excision of polyps and other lesions of unclear pathology 
can also be achieved with this technique14. 
Benign lesions
A shortage of randomized controlled trials exists 
and data can mainly be found as case series, frequently 
with short follow-up. A systematic review from Middleton, 
et al.27 included three comparative studies (including one 
randomized controlled trial) and 55 case series. They 
observed that TEM in adenoma has a recurrence rate of 
5%, a conversion rate of 5.7% (to abdominal resection or 
transanal excision) and a complication rate ranging from 
3-7%. TEM had a lower recurrence rate and lower cost in 
the treatment of adenomas when compared to anterior 
resection or local excision. Some of the studies reviewed 
in this article as well as some other case series will be 
further acknowledged.
Guerrieri, et al.16 reported the experience of six 
Italian centers with 588 adenomas resected by TEM with 
a median follow-up of 44 months. They observed a very 
low incidence of intraoperative complications (0.5%), 
minor complications in 8.2% and major complications 
in 1.2% of the cases. Recurrence rate was 4.3% (23 
patients) been managed by re-TEM (87% of the cases) or 
conventional surgery. There was no mortality.
Ganai, et al.14 removed 109 rectal adenomas with 
a recurrence rate of 15%. They observed that lesions 
previously resected by polypectomies or transanal 
excision had an increased chance of recurrence (32% 
versus 10% for lesions first resected with TEM). They 
also reported an increased chance for recurrence in 
adenomas with high-grade dysplasia (25% versus 11%) 
therefore recommending a closer follow-up for these 
lesions.
McCloud, et al.26 resected 75 adenomas and 
reported complete excision as the main influence 
factor for recurrence. Although macroscopic excision is 
performed, histologic examination of the specimen may 
reveal an inadequate margin in a considerable number 
of cases. Lesions with compromised margins had a 
recurrence rate of 21.4% and 30.8% in six and 12 months, 
respectively, while completely resected adenomas had 
a significant lower recurrence rate (0% and 2.6%, in six 
and 12 months, respectively). In a median follow-up of 
31 months recurrence observed was of 35.7% and 4.3% 
for incomplete and complete excisions, respectively. 
Other authors also observed that not all incomplete 
excisions recurred14,34. This probably occurs due to 
diathermic fulguration effect in the remained borders, 
so incomplete lesions can have earlier surveillance 
instead of rushed reoperation. There was no significant 
difference in recurrence rate for full thickness wall 
excision or mucosectomy in this series. 
In a report of 116 resected adenomas, Palma, et al.30 
observed 3.7% recurrence rate, all successfully managed 
by a second TEM. Similarly, Platell, et al.34 had a 2.4% 
recurrence rate in 62 adenomas, all re-excised by TEM.
From the above data it can conclude that TEM is 
safe and effective in rectal adenomas, allowing a better 
R0 resection when compared to conventional transanal 
approach27. 
Malignant lesions
Large polyps can be hard to differentiate from rectal 
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adenocarcinomas even after several biopsies. When 
facing this uncertainty, the authors perform a EURS and 
TEM is proposed to our patients as a diagnostic tool, 
allowing adequate pathological examination of the 
specimen.
When a malignant lesion is present or suspected, a 
full-thickness resection should be performed.
Low anterior or abdominoperineal resections 
are the definitive procedures in the radical treatment 
of malignant rectal lesions. Total excision of the 
mesorectum with or without preoperative combined 
modality therapy (CMT) has allowed better outcomes 
regarding recurrence and survival. However, patients 
have to experience long operative time and are exposed 
to postoperative complications such as bleeding, suture 
dehiscence, temporary or definitive colostomy, sexual or 
urinary dysfunctions, pneumonia and thromboembolic 
events. In this context, TEM appeared as an attractive 
alternative, however precise preoperative staging is 
imperative since the procedure does not remove all 
perirectal lymph nodes (the risk of its involvement is 
0%-12% for T1 cancers, 12%-28% for T2 cancers, 36%-
79% for T3 cancers25,32,35). Therefore, local recurrence is a 
major concern and careful patient selection is mandatory 
to optimize results. 
Early rectal cancers
For the past decades TEM has been usually 
indicated for patients with low risk T1 adenocarcinomas. 
It is considered a low risk T1 lesion, those with favorable 
prognostic factors such as small size (less than four 
centimeters), absence of invasion of the sm2 or sm3 
levels of the submucosa, well differentiated histology, 
and absence of vascular, lymphatic or perineural 
invasion. When these criteria are respected survival and 
local recurrence rates achieved by TEM are similar to 
those of radical treatment but with limited morbidity 
and mortality17,41. 
Borschitz, et al.2 studied the long term results of 
patients with pT1 lesions resected by TEM. Patients were 
grouped as low or high risk for recurrence accordingly 
to histopathologic findings. The low risk group (R0) 
included 89 patients and observed a recurrence rate 
of 6%, with 10 years cancer-free survival of 89%. The 
high-risk group (R1, Rx, unfavorable histologic criteria) 
included 21 patients and presented a recurrence rate 
of 39%. This study observed that R0 resection in cases 
with low-risk pT1 carcinomas by TEM can be oncologic 
adequate with similar results when compared to primary 
radical surgery for pT1N0M0 rectal lesions. 
Heintz, et al.17 compared the results of TEM and 
radical surgery in 103 patients with T1 rectal carcinomas. 
TEM had significantly lower morbidity and mortality 
rates (3.4% versus 18% and 0% versus 3.8%, respectively). 
Regarding five years survival rate, no difference was 
observed between the procedures in those patients 
with low-risk T1 lesions. In patients with high-risk T1 
carcinomas, lymph node metastases were identified in 
36% of those patients undergoing radical resection and 
recurrence was higher in the TEM group (33% versus 
0%).
Other studies have also demonstrated good results 
with low recurrence and high survival for selected pT1N0 
rectal adenocarcinomas treated by TEM alone2,4,8,13,20,21,36. 
In the advent that pathological examination 
reveals a pT1 lesion with unfavorable features or a more 
advanced lesion the authors recommend complementary 
treatment with radical surgery and/or CMT.
 
Locally advanced rectal cancers
The treatment of T2 and T3 rectal lesions by TEM 
alone has proved to be inadequate with high recurrence 
rates42. This is expected, since the risk of lymph node 
involvement for T2 and T3 rectal adenocarcinomas is 
high (12%-28% and 36%-79%, respectively22,32,35).
Concerning T2 lesions, Lee, et al.21 compared patients 
with T1N0M0 and T2N0M0 rectal adenocarcinomas 
treated by TEM alone (74 patients) or by radical surgery 
(100 patients). No difference was observed concerning 
recurrence and five years survival in the pT1 group. In 
the pT2 group although no statistical difference was 
noted at five years survival rate, the TEM group carried 
an increased risk of local recurrence. They recommend 
careful selection of patients for TEM, counseling that 
when the muscular layer is invaded additional treatment 
should be performed. These findings are in accordance 
with other author’s opinion that local excision alone 
for T2 rectal cancer is inadequate with a high risk for 
recurrence1,13,15,37,38,43. Borschitz, et al.3 demonstrated a 
local recurrence rate of 29% to 50% for low-risk and 
high-risk T2 adenocarcinomas, respectively. Another 
recent study observed in median follow-up of three 
years that 12 patients with T2 rectal adenocarcinomas 
that undergone radiotherapy after TEM remained 
disease free, while a 50% recurrence rate was observed 
in four patients who refused adjuvant treatment10. 
An adequate alternative for T2N0 lesions with 
no distant metastases appears to be neoadjuvant or 
adjuvant therapy associated with TEM43. A prospective 
study with a median follow-up of 84 months included 
70 patients with T2N0 adenocarcinoma at time of 
admission. Patients received preoperative CMT and were 
randomized in two groups (35 patients in each arm): 
one group underwent TEM and the other laparoscopic 
resection with total mesorectal excision. They observed 
similar results in terms of local recurrence, distant 
metastases and survival24. Perhaps if a larger number of 
patients had been enrolled, the recurrence rate (5.7% for 
TEM versus 2.8% for laparoscopic resection) might have 
been statistically significant. 
Lezoche, et al.23 studied patients with small (less 
than 3 cm in diameter) T2-3 N0 distal rectal cancer 
undergoing high-dose radiotherapy before TEM. A total 
of 103 patients were enrolled (54 uT2N0 and 46 uT3N0). 
The definitive histological examination revealed nine pT1, 
54 pT2 and 19 pT3 adenocarcinomas. Complete response 
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or microscopic residual tumor was found in three and 15 
patients, respectively. Minor complications occurred in 
11 patients and major complications in two. At a median 
follow-up of 55 months, local failure rate was 5% and 
metastatic disease was found in two patients. Cancer-
specific survival rate at a 90 months follow-up was 89% 
and overall survival rate 72%. Salvage abdominoperineal 
resection was performed in three patients, two of whom 
were disease free at 15 and 19 months39.
Assessment of tumor response to combined modality 
therapy
Proposing TEM after CMT for locally advanced rectal 
cancer requires confirming downstaging was achieved, 
which is difficult despite the use of all diagnostic tools 
(proctologic examination, EURS, CT, MRI, PET-CT, 
biopsies, serum carcinoembryogenic antigen levels). In 
this context TEM can be performed as a diagnostic tool 
that allows histologic examination and has therapeutic 
properties as well. Certifying complete clinical response 
can be difficult Based on this, TEM can have a major 
role as a diagnostic procedure in the selected group of 
patients who present complete clinical response and in 
those in which recurrence or persistence of tumor cannot 
be ruled out and biopsies only reveal actinic alterations. 
TEM allows pathologic evaluation of the rectal area 
involved with low morbidity.  Currently, TEM can be an 
option for patients with complete clinical response and 
negative biopsies (TNM stage assessed eight weeks after 
the end of CMT). Outside these strict criteria the authors 
believe that only patients enrolled in protocol studies 
should underwent TEM, since radical resection remains 
the therapy of choice. Randomized controlled trials with 
a large number of cases and long follow-up comparing 
TEM with radical resection in patients with incomplete 
response are needed.
Palliation
Another possible indication for TEM is local 
palliation in selected patients with advanced disease, 
and patients that refuse or have a prohibitive risk for 
radical surgery (associated with radiotherapy and/or 
chemoterapy whenever possible). Those patients benefit 
from the limited morbidity and mortality and absence of 
surgical incision, short length of stay and fast recovery.
Carcinoid tumor
Rectal carcinoid tumors present relatively often 
at an early stage without distant metastases because 
they are incidentally found at endoscopy or with rectal 
bleeding. From a histopathological point of view it is 
important to differentiate between low grade carcinoid 
tumors and high grade neuroendocrine carcinomas, as 
the latter have a worse prognosis. Carcinoid tumors do 
not respond to chemotherapy and surgery is the therapy 
of choice. Criteria for local resection of rectal carcinoid 
tumors have been formulated. Unlike rectal carcinomas, 
the diameter of the tumor and the depth of invasion are 
the only relevant parameters for treating rectal carcinoid 
tumors. With a diameter < 1 cm and free margins, 5-year 
survival is reported at 100% after local excision. Invasion 
of the rectal wall is not observed in these tumors. In 
tumors with a diameter of 1 to 2 cm, free margins, and 
no invasion, 5-year survival is also 100%. In cases of 
invasion, 5-year survival drops to 73%. For lesions with 
more than 2 cm diameter, total mesorrectal excision is 
advised19,29. No recurrences has been observed in the 
literature for carcinoid tumors of the rectum and even 
the distal part of the sigmoid treated by TEM, if the 
diameter is <1 cm without invasion of the rectal wall7,18,33. 
Complications 
TEM is usually a quick procedure with an average 
operating time around 67 minutes12,28,34. Complication 
rate is approximately around 10%, being fever, urinary 
retention, rectal bleeding and pain the most common. 
Rare complications are: abdominal perforation, 
transitory fecal incontinence and suture dehiscence with 
pelvic abscess. Few deaths are reported in the literature 
and most are in fact due to metastatic disease in the late 
postoperative or due to advanced disease in cases where 
palliative TEM was performed12,13,14,27,30. Both malignant 
and benign lesions have similar complication rates14. 
Conversion rate is around 5% occurring mainly due to 
technical difficulties.
When compared to rectal resections, such as low 
anterior resection or abdominoperineal resection, TEM 
has a reduced morbidity and mortality, the hospital length 
of stay is shorter and re-operation rate lower. Also, TEM 
is quicker to perform, does not require an abdominal 
incision and significantly reduces postoperative pain.
Concerning the functional results of the procedure, 
there has been some questions about fecal continence, 
since a 40 mm diameter proctoscope is inserted in the 
anus for a few hours. Most studies showed that despite 
manometric alterations can be found in the postoperative 
period they return to normal with time and no detriment 
in fecal continence are notice at any moment6,40. In fact, 
quality of life and even continence are improved after 
tumor removal9.
CONCLUSIONS
TEM is associated with low morbidity and mortality 
is practically nil. TEM is the technique of choice in 
large rectal adenomas, low risk pT1, and selected 
small neuroendocrine tumors localized in the rectal 
ampulla. The frequency of recurrence is similar to that 
in abdominal surgery. The technique does not cause 
complications of urinary or sexual dysfunction and 
fecal incontinence is minimal. In more advances stages 
of rectal adenocarcinoma, the results of better patient 
selection and future studies on the possible application 
of neoadjuvant/adjuvant therapy associated with TEM 
are required.
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